Relative increase of memory B-cell subsets under s.c. B-cell-depleting therapies in multiple sclerosis
Adriana Krenz, Anna-Lena Krickl, Felix Burner, David Freudenstein, Constantin Träger, Timo Wirth, Luisa Klotz, Klemens Angstwurm, De-Hyung Lee, Ralf A. Linker, Stefanie Haase · 2026
Read Relative increase of memory B-cell subsets under s.c. B-cell-depleting therapies in multiple sclerosis by Adriana Krenz, Anna-Lena Krickl, Felix Burner, David Freudenstein, Constantin Träger, Timo Wirth, Luisa Klotz, Klemens Angstwurm, De-Hyung Lee, Ralf A. Linker, Stefanie Haase (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13310750.txt.
Description
Adriana Krenz and colleagues compare B cell clearing drugs for multiple sclerosis in a 2026 blood study. Drugs that remove B cells help many patients, and they can be given by vein drip or by skin injection. Whether the route changes the immune effect was unclear, so the team profiled blood cells in detail.
Groups held 25 patients on each of three drug plans, plus 20 healthy controls. All drugs cut B cells sharply. Patients on skin injections kept a higher share of memory B cells than those on vein drip. People who switched routes also gained memory share over eight weeks. Route may shape long term immune balance.
Catalog record
| CREATOR | Adriana Krenz, Anna-Lena Krickl, Felix Burner, David Freudenstein, Constantin Träger, Timo Wirth, Luisa Klotz, Klemens Angstwurm, De-Hyung Lee, Ralf A. Linker, Stefanie Haase |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27138 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |